A Regulatory Circuit Controlling the Dynamics of NFκB cRel Transitions B Cells from Proliferation to Plasma Cell

Koushik Roy1, Simon Mitchell1, Yi Liu1

  • 1Signaling Systems Laboratory, Institute for Quantitative and Computational Biosciences and Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Immunity
|March 10, 2019
PubMed

Insights

The transcription factor NFκB cRel dynamically regulates B cell differentiation into antibody-secreting cells (ASCs). This study reveals how Blimp1-mediated repression of cRel controls B cell proliferation and ASC generation, offering insights into immune disorders.

Area of Science:

  • Immunology
  • Computational Biology
  • Molecular Biology

Background:

  • Humoral immunity relies on B cell activation and differentiation into antibody-secreting cells (ASCs).
  • The transcription factor NFκB cRel is crucial for B cell proliferation.
  • Previous models struggled to incorporate cRel's regulatory roles in ASC differentiation.

Purpose of the Study:

  • To investigate the role of NFκB cRel in B cell differentiation into ASCs.
  • To develop a mathematical model explaining the dynamic regulation of ASC generation.
  • To elucidate the mechanism by which cRel influences B cell population dynamics.

Main Methods:

  • Mathematical modeling of the B cell differentiation circuit.
  • Incorporation of cRel and Blimp1 regulatory interactions.
  • Simulations of B cell proliferation and ASC generation phases.
  • Analysis of bi-stable circuit dynamics and mutual antagonism between cRel and Blimp1.

Main Results:

  • Ectopic cRel expression inhibited ASC differentiation by blocking the transcription factor Blimp1.
  • In wild-type cells, Blimp1 dynamically repressed cRel during ASC differentiation.
  • A multi-scale model incorporating mutual cRel-Blimp1 antagonism revealed dynamic cRel repression controls the switch between B cell proliferation and ASC generation.
  • This dynamic repression governs cell population dynamics during humoral immune responses.

Conclusions:

  • Dynamic repression of NFκB cRel by Blimp1 is essential for timely ASC generation.
  • Dysregulation of the cRel-Blimp1 bi-stable circuit can lead to pathologic B cell phenotypes.
  • These findings offer potential diagnostic and therapeutic strategies for immune-related diseases.

Related Concept Videos

Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
5.1K
Phase Transitions02:31

Phase Transitions

Whether solid, liquid, or gas, a substance's state depends on the order and arrangement of its particles (atoms, molecules, or ions). Particles in the solid pack closely together, generally in a pattern. The particles vibrate about their fixed positions but do not move or squeeze past their neighbors. In liquids, although the particles are closely spaced, they are randomly arranged. The position of the particles are not fixed—that is, they are free to move past their neighbors to...
23.1K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.7K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
534
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
5.5K
The Cell Cycle Control System02:11

The Cell Cycle Control System

The cell cycle is an organized set of events that leads the cell to divide into two daughter cells, each containing chromosomes identical to the parent cell. It is the cell cycle that leads to the formation of an entire organism from a single-cell zygote. Besides, cell division also functions in the renewal or repair of tissues in adult multicellular eukaryotes. For example, in the bone marrow, the stem cells divide to form new blood cells. Although essential for several functions, cell...
14.2K